Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• UBS analyst Weston Bloomer upgraded Arthur J. Gallagher & Co. (NYSE:AJG) from Neutral to Buy and lowers the price target from $283 to $250. Arthur J. Gallagher shares closed at $212.52 on Monday. See how other analysts view this stock.
• Sidoti & Co. analyst Steve Ferazani upgraded Brady Corp (NYSE:BRC) from Neutral to Buy and announced a $103 price target. Brady shares closed at $75.28 on Monday. See how other analysts view this stock.
• GLJ Research analyst Gordon L. Johnson upgraded Cleveland-Cliffs Inc (NYSE:CLF) from Sell to Hold and raised the price target from $9.03 to $15.01. Cleveland-Cliffs shares closed at $12.68 on Monday. See how other analysts view this stock.
• JP Morgan analyst Ella Smith upgraded PAR Technology Corporation (NYSE:PAR) from Underweight to Neutral and raised the price target from $12 to $16. PAR Technology shares closed at $13.28 on Monday. See how other analysts view this stock.
• Barclays analyst Luke Sergott upgraded West Pharmaceutical Services, Inc. (NYSE:WST) from Equal-Weight to Overweight and raised the price target from $310 to $400. West Pharmaceutical shares closed at $319.75 on Monday. See how other analysts view this stock.

Considering buying BRC stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.